• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体内依酚氯铵的血浆浓度。

Plasma concentration of edrophonium in man.

作者信息

Calvey T N, Williams N E, Muir K T, Barber H E

出版信息

Clin Pharmacol Ther. 1976 Jun;19(6):813-20. doi: 10.1002/cpt1976196813.

DOI:10.1002/cpt1976196813
PMID:1269219
Abstract

The plasma concentration of edrophonium was measured in man after intravenous administration. In 5 patients, the clearance of edrophonium from the circulation during the 1-hr period of sampling was invariably resolved into 2 exponential components. An initial rapid phase of elimination from plasma (T/2 = 0.54 TO 1.92 Min) was followed by a much slower decline (T/2 = 24.23 to 45.00 Min), corresponding to the fall in concentration between 10 and 60 min. In parallel experiments in the rat, the clearance of 14C-edrophonium was resolved into 3 exponential components, although the final component could not be reliably defined until 1 to 3 hr after intravenous injection. It is suggested that the rapid fall in the plasma concentration of edrophonium in both species is not dependent on metabolism or excretion, but is due to the rapid uptake of the drug by the liver and kidneys.

摘要

静脉注射后,在人体中测量了依酚氯铵的血浆浓度。在5名患者中,在1小时采样期间依酚氯铵从循环中的清除率始终分解为2个指数成分。血浆中最初的快速消除期(T/2 = 0.54至1.92分钟)之后是慢得多的下降(T/2 = 24.23至45.00分钟),对应于10至60分钟之间的浓度下降。在大鼠的平行实验中,14C-依酚氯铵的清除率分解为3个指数成分,尽管直到静脉注射后1至3小时才能可靠地确定最终成分。有人提出,两种物种中依酚氯铵血浆浓度的快速下降不依赖于代谢或排泄,而是由于肝脏和肾脏对药物的快速摄取。

相似文献

1
Plasma concentration of edrophonium in man.人体内依酚氯铵的血浆浓度。
Clin Pharmacol Ther. 1976 Jun;19(6):813-20. doi: 10.1002/cpt1976196813.
2
The pharmacokinetics of (14C)-edrophonium in normal wistar rats and homozygous Gunn rats with ligated renal pedicles.(14C)-依酚氯铵在正常Wistar大鼠和肾蒂结扎的纯合子Gunn大鼠中的药代动力学。
Br J Pharmacol. 1974 May;51(1):61-5. doi: 10.1111/j.1476-5381.1974.tb09632.x.
3
The effect of edrophonium on erythrocyte acetylcholinesterase and neuromuscular function in the rat.依酚氯铵对大鼠红细胞乙酰胆碱酯酶及神经肌肉功能的影响
Br J Pharmacol. 1976 Jan;56(1):93-9. doi: 10.1111/j.1476-5381.1976.tb06963.x.
4
The removal of 14 C-edrophonium from the circulation.14C-依酚氯铵从循环系统中的清除。
Br J Pharmacol. 1972 Oct;46(2):355-7. doi: 10.1111/j.1476-5381.1972.tb06882.x.
5
Proceedings: The relation between the plasma concentration of edrophonium, inhibition of erythrocyte acetylcholinesterase, and the facilitation of neuromuscular function in the rat.论文:大鼠体内依酚氯铵血浆浓度、红细胞乙酰胆碱酯酶抑制作用与神经肌肉功能促进之间的关系
Br J Pharmacol. 1975 Jun;54(2):263P-264P.
6
Pharmacokinetics of edrophonium in anephric and renal transplant patients.依酚氯铵在无肾和肾移植患者中的药代动力学。
Br J Anaesth. 1981 Dec;53(12):1311-4. doi: 10.1093/bja/53.12.1311.
7
The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium.季铵类抗胆碱酯酶药物新斯的明、吡啶斯的明、依酚氯铵和3-羟基苯基三甲基铵的药代动力学、胆碱酯酶抑制作用与抽搐张力增强之间的关系。
Br J Pharmacol. 1979 Aug;66(4):525-30. doi: 10.1111/j.1476-5381.1979.tb13690.x.
8
Excretion of 14 C-edrophonium and its metabolites in bile: role of the liver cell and the peribiliary vascular plexus.14C-依酚氯铵及其代谢产物在胆汁中的排泄:肝细胞和胆小管周围血管丛的作用。
Br J Pharmacol. 1972 Mar;44(3):534-43. doi: 10.1111/j.1476-5381.1972.tb07290.x.
9
Pharmacokinetics and pharmacological effects of neostigmine in man.新斯的明在人体中的药代动力学和药理作用。
Br J Clin Pharmacol. 1979 Feb;7(2):149-55. doi: 10.1111/j.1365-2125.1979.tb00915.x.
10
Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.米库氯铵输注后深度神经肌肉阻滞逆转所需的依酚氯铵量。
Can J Anaesth. 1995 Nov;42(11):996-1002. doi: 10.1007/BF03011072.

引用本文的文献

1
Evaluation of the Edrophonium Challenge Test for Cervical Dystonia.用于颈部肌张力障碍的依酚氯铵激发试验的评估
Intern Med. 2017 Sep 15;56(18):2415-2421. doi: 10.2169/internalmedicine.8555-16. Epub 2017 Aug 21.
2
Edrophonium Challenge Test for Blepharospasm.用于眼睑痉挛的依酚氯铵激发试验。
Front Neurosci. 2016 Jun 6;10:226. doi: 10.3389/fnins.2016.00226. eCollection 2016.
3
Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.大鼠体内胆碱酯酶抑制剂对收缩增强作用的药效学分析
J Pharmacokinet Biopharm. 1996 Aug;24(4):327-48. doi: 10.1007/BF02353516.
4
Compartment- and model-independent linear plateau principle of drugs during a constant-rate absorption or intravenous infusion.
J Pharmacokinet Biopharm. 1980 Jun;8(3):311-8. doi: 10.1007/BF01059648.
5
Clinical pharmacokinetics of cholinesterase inhibitors.胆碱酯酶抑制剂的临床药代动力学。
Clin Pharmacokinet. 1986 May-Jun;11(3):236-49. doi: 10.2165/00003088-198611030-00005.
6
New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.新型静脉麻醉药和神经肌肉阻滞药。其特性及临床应用综述。
Drugs. 1987 Jul;34(1):98-135. doi: 10.2165/00003495-198734010-00004.
7
Pharmacokinetics of propantheline bromide in normal man.溴丙胺太林在正常人体内的药代动力学。
Br J Clin Pharmacol. 1979 Jan;7(1):89-93. doi: 10.1111/j.1365-2125.1979.tb00902.x.
8
Pharmacokinetics and pharmacological effects of neostigmine in man.新斯的明在人体中的药代动力学和药理作用。
Br J Clin Pharmacol. 1979 Feb;7(2):149-55. doi: 10.1111/j.1365-2125.1979.tb00915.x.